(Q44342915)

English

Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system

scientific article published on September 5, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system (English)

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

0 references

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

author name string

Hideo Umeuchi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Yuko Togashi

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Toshiyuki Honda

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kaoru Nakao

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kiyoshi Okano

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Toshiaki Tanaka

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hiroshi Nagase

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5 September 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14512095

14 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0014299903022015?httpAccept=text/xml

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

https://api.elsevier.com/content/article/PII:S0014299903022015?httpAccept=text/plain

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

477

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

29-35

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice

1

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Itching after epidural and spinal opiates

2

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Novel developments with selective, non-peptidic kappa-opioid receptor agonists

3

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Opiates, mast cells and histamine release

4

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Open-label trial of oral nalmefene therapy for the pruritus of cholestasis

5

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study

6

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Antipruritic and antihyperalgesic actions of loperamide and analogs

8

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Treatment of pruritus due to chronic obstructive liver disease

9

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines

10

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Experimental and clinical pruritus. Studies on some putative peripheral mediators. The influence of ultraviolet light and transcutaneous nerve stimulation

11

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Opioid antagonists in the treatment of opioid-induced constipation and pruritus

12

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis

13

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus

14

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Pruritus: pathogenesis, therapy, and significance in systemic disease states

15

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Flare and Itch Induced by Substance P in Human Skin

16

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse

17

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis

19

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Mouse ear PCA as a model for evaluating antianaphylactic agents

20

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

The pruritus of cholestasis

21

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice

22

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Pharmacologic therapy for urticaria

23

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Scratching behavior induced by pruritogenic but not algesiogenic agents in mice

24

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis

25

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

A novel method for counting spontaneous motor activity in the rat.

26

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis

27

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan

28

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice

29

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

mu-Opposing actions of the kappa-opioid receptor

31

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Randomised crossover trial of naltrexone in uraemic pruritus

32

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

33

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Specific C-receptors for itch in human skin.

34

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin.

35

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays

36

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Multiple effects of morphine on facial scratching in monkeys

37

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Opioid peptides and primary biliary cirrhosis

38

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Plasma beta endorphin in cirrhosis and renal failure

39

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.

40

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Intracisternal injection of opioids induces itch-associated response through mu-opioid receptors in mice.

41

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice

42

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice

43

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Pathophysiology of itching in urticaria and atopic dermatitis

44

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Codeine for pruritus in primary billiary cirrhosis

45

1 reference

10.1016/J.EJPHAR.2003.08.007

https://api.crossref.org/works/10.1016/J.EJPHAR.2003.08.007

14 March 2024

Identifiers

10.1016/J.EJPHAR.2003.08.007

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44342915&oldid=2102134962"